4//SEC Filing
Fonstein Michael 4
Accession 0001144204-12-003981
CIK 0001318641other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 9:19 PM ET
Size
5.3 KB
Accession
0001144204-12-003981
Insider Transaction Report
Form 4
Fonstein Michael
DirectorCEO, President
Transactions
- Award
Employee Stock Options (Right to Buy)
2012-01-23+56,250→ 56,250 totalExercise: $3.35From: 2012-01-23Exp: 2022-01-23→ Common Stock (56,250 underlying)
Footnotes (1)
- [F1]On January 23, 2012, with the approval of the Compensation Committee, Cleveland BioLabs, Inc. issued stock options to Dr. Fonstein per the 2011 Executive Compensation Plan.
Documents
Issuer
CLEVELAND BIOLABS INC
CIK 0001318641
Entity typeother
Related Parties
1- filerCIK 0001369806
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 9:19 PM ET
- Size
- 5.3 KB